SCHEMBL8360877

SCHEMBL8360877

Cc1ccc(S(=O)(=O)N(Cc2ccccc2)C2CCCN(C(=O)OC(C)(C)C)C2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.52
JAK1 P23458 1/20 0.52
ALDH1A1 P00352 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
TP53 P04637 1/20 0.47
ALOX15 P16050 1/20 0.47
MAPK1 P28482 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CNR1 P21554 2/20 0.47
CNR2 P34972 2/20 0.47
USP30 Q70CQ3 3/20 0.47
MEN1 O00255 1/20 0.45
LMNA P02545 1/20 0.45
HTT P42858 1/20 0.45
KMT2A Q03164 1/20 0.45
STS P08842 1/20 0.45
HSD11B1 P28845 1/20 0.45
STAT3 P40763 1/20 0.44
PRMT5 O14744 2/20 0.44
WDR77 Q9BQA1 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8360875 0.92 JAK2 (0.51) JAK2JAK1USP30MEN1KMT2A
SCHEMBL8360879 0.92 JAK2 (0.51) JAK2JAK1ALDH1A1USP30MEN1
SCHEMBL8363941 0.92 JAK2 (0.51) JAK2JAK1USP30MEN1KMT2A
SCHEMBL8360881 0.92 KMT2A (0.52) JAK2JAK1ALDH1A1ALOX15USP30
SCHEMBL8360876 0.91 KCNA5 (0.55) JAK2JAK1ALDH1A1L3MBTL1CNR1
SCHEMBL2960832 0.89 STS (0.52) JAK2JAK1ALDH1A1NPSR1TP53
SCHEMBL8363938 0.89 CNR1 (0.46) ALDH1A1NPSR1TP53ALOX15MAPK1
SCHEMBL8363842 0.86 CNR1 (0.54) ALDH1A1L3MBTL1CNR1CNR2MEN1
SCHEMBL8363934 0.83 MMP1 (0.48) ALDH1A1CNR1CNR2USP30MEN1
SCHEMBL24424432 0.82 JAK2 (0.61) JAK2JAK1USP30KMT2ASTS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003013527-A1 SULFONAMIDE DERIVATIVES AS GAMMA SECRETASE INHIBITORS SCHERING CORPORATION (US) 2003-02-20 WO disclosed